anecortave acetate

DRUG13 trials

Sponsors

Alcon Research, Manhattan Eye, Ear & Throat Hospital, University of Iowa, Texas Retina Associates, Cornea Research Foundation of America

Conditions

AMDAge-Related Macular Degenerations.Central Retinal Vein OcclusionChronic Central Serous ChorioretinopathyChronic InflammationCoat's DiseaseEye InjuriesGlaucoma

Phase 1

Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate

CompletedNCT00489840

Manhattan Eye, Ear & Throat HospitalChronic Central Serous Chorioretinopathy

Start: 2007-05-31Updated: 2012-10-25

Prophylactic Anecortave Acetate in Patients With a Retisert Implant

CompletedNCT00570479

Texas Retina AssociatesGlaucoma, Uveitis, Posterior

Start: 2006-09-30End: 2010-03-31Updated: 2012-06-05

Phase 2

Treatment of Retinal Vein Occlusion (RVO) With Open-Label Anecortave Acetate (15mg.)

WithdrawnNCT00211354

Manhattan Eye, Ear & Throat HospitalRetinal Vein Occlusion

Start: 2002-03-31End: 2007-04-30Updated: 2009-02-04

Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.).

TerminatedNCT00211471

Manhattan Eye, Ear & Throat HospitalCentral Retinal Vein Occlusion, Chronic Inflammation, Infectious Diseases +1

Start: 2002-03-31End: 2007-05-31Updated: 2007-05-07

Treatment of Idiopathic Perifoveal Telangiectasia (IPT) With Open-Label Anecortave Acetate (15mg.).

CompletedNCT00211328

Manhattan Eye, Ear & Throat HospitalIdiopathic Perifoveal Telangiectasia

Start: 2002-03-31End: 2007-03-31Updated: 2009-02-04

Treatment of Radiation Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg)

TerminatedNCT00211367

Manhattan Eye, Ear & Throat HospitalEye Injuries

Start: 2004-04-30End: 2007-03-31Updated: 2007-06-21

Treatment of Conditions With Open Label-Anecortave Acetate Sterile Suspension ( 15mg.) Where Lesions do Not Meet Acceptable Criteria for Standard Care.

CompletedNCT00211484

Manhattan Eye, Ear & Throat HospitalAge-Related Macular Degenerations., Subfoveal Neovascularization.

Start: 2003-05-31End: 2007-03-31Updated: 2007-05-07

Treatment of Congenital Telangiectasia (Coat's Disease) With Open-label Anecortave Acetate (15mg.)

CompletedNCT00211315

Manhattan Eye, Ear & Throat HospitalCoat's Disease

Start: 2002-03-31End: 2007-03-31Updated: 2012-10-24

Anecortave Acetate Versus Placebo in AMD Patients Following PDT

CompletedNCT00346866

Alcon ResearchAMD

Start: 2000-05-31End: 2001-12-31Target: 136Updated: 2008-08-05

A Multi-Dose Study With a Treatment for Open-Angle Glaucoma

WithdrawnNCT00705770

Alcon ResearchOpen-Angle Glaucoma

Start: 2008-05-31End: 2008-07-31Updated: 2012-05-30

Phase 3

An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal CNV Due to Exudative AMD

CompletedNCT00058994

Alcon ResearchMacular Degeneration, Maculopathy, Age-Related

Start: 2003-03-31End: 2006-11-30Updated: 2012-11-29

Unknown Phase

Treatment of Patients With Age-Related Macular Degeneration With Anecortave Acetate

University of IowaMacular Degeneration

Start: 2003-01-31End: 2008-08-31Updated: 2010-01-15

Anecortave Acetate Injection to Treat Steroid-responsive Intraocular Pressure Increase in Cornea Transplant Patients

TerminatedNCT00884039

Cornea Research Foundation of AmericaIntraocular Pressure, Transplant

Start: 2009-05-31End: 2010-09-30Updated: 2018-08-14